These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32517741)

  • 41. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. European cardiac nurses' current practice and knowledge on anticoagulation therapy.
    Oterhals K; Deaton C; De Geest S; Jaarsma T; Lenzen M; Moons P; Mårtensson J; Smith K; Stewart S; Strömberg A; Thompson DR; Norekvål TM
    Eur J Cardiovasc Nurs; 2014 Jun; 13(3):261-9. PubMed ID: 23711557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AParadigm Shift: The New Novel Oral Anticoagulation Agents.
    Saeed W; Burke JF; Mirrani G; Sirinivasa M; Nabi U; Hayat U; Khan Z; Sardar MR
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):611-9. PubMed ID: 27504556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
    Pengo V; Cucchini U; Denas G; Davidson BL; Marzot F; Jose SP; Iliceto S
    Thromb Haemost; 2010 Feb; 103(2):442-9. PubMed ID: 20076843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of Warfarin Anticoagulant Reaction in Patients with Repeated Oral Tolvaptan Administration.
    Saito M; Ajioka M; Iwao T; Suzuki T
    Biol Pharm Bull; 2018 Jul; 41(7):1014-1016. PubMed ID: 29760305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin.
    Praxedes MFS; Martins MAP; Mourão AOM; Gomes KB; Reis EA; Souza RP; Campos EIF; Ribeiro DD; Rocha MOC
    Eur J Clin Pharmacol; 2020 Feb; 76(2):199-209. PubMed ID: 31720756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constant use of oral anticoagulants: implications in the control of their adequate levels.
    Esmerio FG; Souza EN; Leiria TL; Lunelli R; Moraes MA
    Arq Bras Cardiol; 2009 Nov; 93(5):549-54. PubMed ID: 20084318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetaminophen and other risk factors for excessive warfarin anticoagulation.
    Hylek EM; Heiman H; Skates SJ; Sheehan MA; Singer DE
    JAMA; 1998 Mar; 279(9):657-62. PubMed ID: 9496982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interventions to improve anticoagulation with warfarin.
    Castro TA; Heineck I
    Ther Drug Monit; 2012 Apr; 34(2):209-16. PubMed ID: 22406649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.
    Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM
    PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A factor VII-based method for the prediction of anticoagulant response to warfarin.
    Ooi QX; Wright DFB; Isbister GK; Duffull SB
    Sci Rep; 2018 Aug; 8(1):12041. PubMed ID: 30104739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new regimen for starting warfarin therapy in out-patients.
    Oates A; Jackson PR; Austin CA; Channer KS
    Br J Clin Pharmacol; 1998 Aug; 46(2):157-61. PubMed ID: 9723825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.
    Yu CY; Campbell SE; Zhu B; Knadler MP; Small DS; Sponseller CA; Hunt TL; Morgan RE
    Curr Med Res Opin; 2012 Feb; 28(2):187-94. PubMed ID: 22149769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of patients' knowledge about oral anticoagulant medicines and use of alert cards by community pharmacists.
    Jani YH; Hirani B; Livingstone C
    Int J Clin Pharm; 2021 Feb; 43(1):203-211. PubMed ID: 32893324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial.
    Zhang Q; Bal-dit-Sollier C; Drouet L; Simoneau G; Alvarez JC; Pruvot S; Aubourg R; Berge N; Bergmann JF; Mouly S; Mahé I
    Eur J Clin Pharmacol; 2011 Mar; 67(3):309-14. PubMed ID: 21191575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amoxicillin/clavulanic acid-warfarin drug interaction: a randomized controlled trial.
    Zhang Q; Simoneau G; Verstuyft C; Drouet L; Bal dit Sollier C; Alvarez JC; Rizzo-Padoin N; Bergmann JF; Becquemont L; Mouly S
    Br J Clin Pharmacol; 2011 Feb; 71(2):232-6. PubMed ID: 21219403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.